Monash IVF pays millions to families after horror embryo mix-ups
Families involved in two horrific messes in which women were implanted with the wrong embryos received huge secret settlements from Monash IVF.
The fertility giant this week confirmed it had reached settlements with families involved in embryo nodes at its Brisbane and Clayton clinics, which came to light four months apart last year.
Sources familiar with the agreements, but who could not speak publicly due to the confidential nature of the agreements, revealed that the compensation included payments of several million dollars to the families.
Families directly affected included both the biological mother and birth mother from the Brisbane incident, as well as at least one family involved in the Clayton error.
Monash IVF announced in February 2025 that an embryo transfer error at its Brisbane facility had occurred nearly a year earlier. Queensland woman gives birth to foreigner’s baby.
Investigations into the Brisbane scandal had to be expanded after the company admitted the wrong embryo was implanted in a different woman during a procedure at the Clayton clinic on June 5.
On Thursday a Monash IVF spokesperson confirmed that agreement had been reached with all parties involved in the two-embryo mix.
“The company has settled or agreed to settle financial claims arising from the Brisbane, Queensland and Clayton, Victoria events, which were previously disclosed to the market,” a Monash IVF spokesperson said.
“We deeply regret the events that occurred in 2025 and have taken important steps to strengthen our security culture and improve oversight across all sites.
“We have also worked closely with the regulator to ensure our systems meet and, where possible, exceed required standards and community expectations.
“Patients can be assured that we have learned from these incidents and are taking decisive action to ensure our systems are as rigorous and robust as possible.”
Monash IVF also said in its half-yearly results report to the Australian Securities Exchange in February that insurers had confirmed claims arising from both events and that large compensation payments would not impact shareholders.
Monash IVF told the market: “Based on information available at the reporting date and taking into account the insurance cover in place, the directors do not expect any material risks to arise in connection with these matters.”
Embryo errors sent shockwaves through Australia’s fertility industry and led to an urgent overhaul of Australia’s reproductive technology regulation; In addition, there has been heartbreak for at least three families directly affected and distress for thousands of women who have had their own procedures.
It also damaged the reputation of one of the world’s oldest and most respected fertility businesses, with Monash IVF’s share price initially falling and chief executive Michael Knapp resigning two weeks after the Clayton blunder.
The full findings of the review by Monash IVF commissioner Fiona McLeod, SC, remain confidential, but details released revealed “human error” was at the heart of both embryo mix-ups.
McLeod found that the two incidents were unrelated, different in nature, and occurred years apart. Its review found that both cases involved substandard IVF treatment and conditions that would not usually occur in most procedures.
While the insertion of the wrong embryo into a woman in Brisbane was solely the result of human error, McLeod found that the Clayton mix-up was caused by a number of factors, including human error at many stages and limitations in the IT system.
The review found that these limitations ultimately make the transfer process more vulnerable to human errors.
Start your day with a summary of the day’s most important and interesting stories, analysis and insights. Sign up for our Morning Edition newsletter.
